NA-1

DRUG2 trials

Sponsors

NoNO Inc.

Conditions

Ruptured Intracranial AneurysmStrokeSubarachnoid Hemorrhage

Phase 2

Evaluating Neuroprotection in Aneurysm Coiling Therapy

CompletedNCT00728182

NoNO Inc.Stroke

Start: 2008-08-31End: 2011-05-31Updated: 2013-10-17

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

WithdrawnNCT02056574

NoNO Inc.Ruptured Intracranial Aneurysm, Subarachnoid Hemorrhage

Start: 2015-11-30End: 2020-04-30Updated: 2015-08-04

Related Papers

Association of Iatrogenic Infarcts With Clinical and Cognitive Outcomes in the Evaluating Neuroprotection in Aneurysm Coiling Therapy Trial.

PubMed2022-04-058 citations

Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.

2012-10-08301 citations